Search Results - "Smedmyr, B."

MINIMAL RESIDUAL DISEASE IN ADULTS WITH PHILADELPHIA NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA A SWEDISH POPULATION-BASED STUDY by Bergfelt, E., Kozlowski, P., Ahlberg, L., Hulegardh, E., Hagglund, H., Karlsson, K., Markuszewska-Kuczymska, Alicja, Tomaszewska-Toporska, B., Smedmyr, B., Astrom, M., Amini, R. M., Hallbook, H.

Get full text

An investigation into whether deletions in 9p reflect prognosis in adult precursor B-cell acute lymphoblastic leukemia: a multi-center study of 381 patients by Nahi, Hareth, Hagglund, Hans, Ahlgren, Thomas, Bernell, Per, Hardling, Mats, Karlsson, Karin, Lazarevic, Vladimir Lj, Linderholm, Mats, Smedmyr, Bengt, Astrom, Maria, Hallbook, Helene

“…1 Department of Haematology, Karolinska University Hospital 2 Department of Haematology, Malmö University Hospital 3 Department of Haematology, Sahlgrenska…”
Get full text

Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience by HALLBÖÖK, H, HÄGGLUND, H, STOCKELBERG, D, NILSSON, P.-G, KARLSSON, K, BJÖRKHOLM, M, LINDERHOLM, M, WAHLIN, A, LINDER, O, SMEDMYR, B

“…Adult patients with acute lymphoblastic leukaemia (ALL) have been treated according to national protocols in Sweden since 1986. Stem cell transplantation (SCT)…”
Get full text

Mobilization of CD34+ cells by glycosylated and nonglycosylated G-CSF in healthy volunteers - a comparative study by Höglund, M., Smedmyr, B., Bengtsson, M., Tötterman, T. H., Cour-Chabernaud, V., Yver, A., Simonsson, B.

“…: In vitro studies indicate that lenograstim (glycosylated G–CSF) is more potent than filgrastim (nonglycosylated G–CSF) on a weight for weight basis. However,…”
Get full text

Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF by Höglund, M, Smedmyr, B, Simonsson, B, Tötterman, T, Bengtsson, M

“…In an attempt to optimise the dose of G-CSF for mobilisation of PBPC in allogeneic donors, four groups of six healthy male volunteers received lenograstim…”
Get more information

Pulmonary function and complications subsequent to autologous bone marrow transplantation by Carlson, K, Bäcklund, L, Smedmyr, B, Oberg, G, Simonsson, B

“…Risk factors for early pulmonary complications occurring within the first 3 months after autologous bone marrow transplantation (BMT) were analysed in 158…”
Get more information

Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology by HASSAN, M, ÖBERG, G, SIMONSSON, B, BEKASSY, A. N, ASCHAN, J, EHRSSON, H, LJUNGMAN, P, LÖNNERHOLM, G, SMEDMYR, B, TAUBE, A, WALLIN, I

“…Busulphan levels in plasma were measured in 27 patients during conditioning therapy (1 mg/kg x 4 for 4 days) before bone marrow transplantation. The mean…”
Get full text

Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol by Hallböök, Helene, Gustafsson, Göran, Smedmyr, Bengt, Söderhäll, Stefan, Heyman, Mats

“…Several studies have reported a more favorable outcome for teenagers and young adults with acute lymphoblastic leukemia (ALL) when they were treated in…”
Get full text

Pharmacokinetic and metabolic studies of high-dose busulphan in adults by HASSAN, M, ÖBERG, G, EHRSSON, H, EHRNEBO, M, WALLIN, I, SMERDMYR, B, TÖTTERMAN, T, EKSBORG, S, SIMONSSON, B

“…The pharmacokinetics of high-dose busulphan was studied in adult patients with acute myeloblastic leukaemia after oral doses of 1 mg.kg-1 every 6 h for 4 days…”
Get full text

Stimulation of NK cell, T cell, and monocyte functions by the novel immunomodulator Linomide after autologous bone marrow transplantation. A pilot study in patients with acute myeloid leukemia by Bengtsson, M, Simonsson, B, Carlsson, K, Nilsson, B, Smedmyr, B, Termander, B, Oberg, G, Tötterman, T H

“…Immunostimulatory therapy is at present considered after autologous bone marrow transplantation (ABMT) in order to mimic the allogeneic graft-versus-leukemia…”
Get more information

Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation by Pauksen, K, Duraj, V, Ljungman, P, Sjölin, J, Oberg, G, Lönnerholm, G, Fridell, E, Smedmyr, B, Simonsson, B

“…Humoral immunity to measles, rubella and mumps was studied in 63, 36 and 16 patients 1, 2 and 3 years, respectively after autologous bone marrow…”
Get more information

Serum osteocalcin concentrations in patients with multiple myeloma--correlation with disease stage and survival by Carlson, K, Ljunghall, S, Simonsson, B, Smedmyr, B

“…Multiple myeloma affects bone, and enhanced bone resorption is a characteristic finding. In the present study the serum concentration of osteocalcin, serum…”
Get more information

Subclinical disturbances in cardiac function at rest and in gas exchange during exercise are common findings after autologous bone marrow transplantation by Carlson, K, Smedmyr, B, Bäcklund, L, Simonsson, B

“…A study was undertaken to examine the effects of autologous bone marrow transplantation (BMT) on cardiac function at rest (n = 111) and pulmonary gas exchange…”
Get more information

Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) +/- TBI and autologous BMT for malignant lymphomas by Carlson, K, Smedmyr, B, Hagberg, H, Oberg, G, Simonsson, B

“…Twenty-four patients autografted for malignant lymphoma have been followed. All were conditioned with BEAC (BCNU, etoposide, ara-C, cyclophosphamide), in 10…”
Get more information

Pulmonary function after autologous bone marrow transplantation in children by Arvidson, J, Bratteby, L E, Carlson, K, Hagberg, H, Kreuger, A, Simonsson, B, Smedmyr, B, Taube, A, Oberg, G, Lönnerholm, G

“…Forty-two children receiving bone marrow autografts were studied prospectively regarding acute pulmonary complications; there was no procedure-related…”
Get more information

Thyroid function after autologous bone marrow transplantation by Carlson, K, Lönnerholm, G, Smedmyr, B, Oberg, G, Simonsson, B

“…Thyroid function was prospectively analysed in 111 consecutive patients in relation to autologous bone marrow transplantation (ABMT). Median follow-up time was…”
Get more information

Cerebrospinal fluid and plasma concentrations of busulfan during high-dose therapy by Hassan, M, Ehrsson, H, Smedmyr, B, Tötterman, T, Wallin, I, Oberg, G, Simonsson, B

“…A patient with acute myeloblastic leukemia received high-dose busulfan (1 mg/kg by mouth every 6 h for 4 days) as myelo-ablative therapy for autologous bone…”
Get more information

High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden by Kozlowski, Piotr, Åström, Maria, Ahlberg, Lucia, Bernell, Per, Hulegårdh, Erik, Hägglund, Hans, Karlsson, Karin, Markuszewska-Kuczymska, Alicja, Tomaszewska-Toporska, Beata, Smedmyr, Bengt, Amini, Rose-Marie, Hallböök, Helene

“…Background Hyper‐CVAD is widely used to treat acute lymphoblastic leukemia (ALL) and aggressive lymphomas. This multicenter, population‐based study assessed…”
Get full text

The effect of rGM-CSF on neutrophil and eosinophil regeneration after ABMT as monitored by circulating levels of granule proteins by Höglund, M, Simonsson, B, Smedmyr, B, Oberg, G, Venge, P

“…In order to further evaluate the effects of rGM-CSF on the reconstituting granulopoiesis, plasma and serum levels of myeloperoxidase (MPO) and lactoferrin…”
Get more information

Impaired glucose tolerance after autologous bone marrow transplantation by Smedmyr, B, Wibell, L, Simonsson, B, Oberg, G

“…In this study we investigated glucose tolerance in relation to autologous bone marrow transplantation (ABMT). In 13 adult patients with acute myeloblastic…”
Get more information